Morphic Holding Inc

General ticker "MORF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.8B

Morphic Holding Inc follows the US Stock Market performance with the rate: 25.7%.

Estimated limits based on current volatility of 0.0%: low 56.96$, high 56.99$

Factors to consider:

  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [13.48$, 35.99$]
  • 2024-12-30 to 2025-12-30 estimated range: [11.42$, 29.96$]

Financial Metrics affecting the MORF estimates:

  • Negative: Non-GAAP EPS of -3.49 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: negative Net Income
  • Negative: Operating Cash Flow per share of -2.65 <= 0.20
  • Positive: Interest Expense per share of 0 <= 0
  • Negative: Industry Operating Cash Flow per share (median) of -1.55 <= 0.28

Similar symbols

Short-term MORF quotes

Long-term MORF plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $19.79MM $70.81MM $0.52MM
Operating Expenses $115.60MM $134.20MM $179.21MM
Operating Income $-95.81MM $-63.40MM $-178.69MM
Non-Operating Income $0.26MM $4.42MM $26.97MM
Interest Expense $0.00MM $4.57MM $0.00MM
R&D Expense $87.79MM $102.06MM $140.38MM
Income(Loss) $-95.54MM $-58.97MM $-151.72MM
Taxes $0.00MM $0.07MM $0.38MM
Profit(Loss) $-95.54MM $-59.04MM $-152.09MM
Stockholders Equity $336.70MM $349.12MM $697.02MM
Assets $426.29MM $368.59MM $722.51MM
Operating Cash Flow $-83.46MM $-100.98MM $-112.31MM
Investing Cash Flow $-113.18MM $-56.45MM $-341.81MM
Financing Cash Flow $266.31MM $45.27MM $453.43MM
Earnings Per Share* $-2.63 $-1.55 $-3.59

* EPS are Split Adjusted, recent splits may be reflected with a delay.